FromJulie Anne Overton ([email protected])
Subject (90)bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
Preheader (150)News ReleasebioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungSales of CyPath® Lung tests continue to accelera
Typography
Arial
Colors
Text Analysis
Body Words2048
Subject Words13
Body Emojis33
Subject Emojis1
Media Analysis
Text Links15
Image Links3
Total Links18
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px3284 px
X-Spam Score0.0
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeOvernight

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

News ReleasebioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungSales of CyPath® Lung tests continue to accelera
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung